|Bid||15.10 x 0|
|Ask||15.17 x 0|
|Day's Range||14.65 - 16.64|
|52 Week Range||8.62 - 24.75|
|Beta (3Y Monthly)||3.96|
|PE Ratio (TTM)||84.17|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.56|
Yahoo Finance's Adam Shapiro, Julie Hyman, and Rick Newman talk to CB1 Capital's Todd Harrison about the future of cannabis and hemp amid 2018's midterm elections.
CORAL GABLES, FL / ACCESSWIRE / November 8, 2018 / Marijuana stocks have seen a surge of attention this year. This event has been well received by the public markets as many marijuana stocks have positively reacted to this news. Sessions, who has been a staunch adversary of the legalization of cannabis, took a very conservative approach when broaching the subject.
Toronto, Burlington, Ontario--(Newsfile Corp. - November 5, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) have signed a definitive agreement granting Aphria exclusive preferred global vendor status for the production and sales of RDT's QuickStrip™ technology for both medicinal and adult-use cannabis markets around the world. RDT's game-changing, proprietary QuickStrip™ technology is a Quick, ...
CORAL GABLES, FL / ACCESSWIRE / November 2, 2018 / The recent boom for things like medical marijuana in the UK as well as the rise of healthcare technology have investors interested in new and exciting companies. Recent developments across both sectors have new companies targeting expanded market share. Technology has become a major part of the healthcare industry, as we know it.
LEAMINGTON, ON , Nov. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has been granted a Manufacture Licence by the Australian Government's Office of Drug Control. The license provides Althea with authorization to manufacture extracts and tinctures of cannabis and cannabis resin in accordance with relevant manufacture permits. "We are excited to see our Australian partner achieve yet another milestone in receiving its Manufacture License.
* The Toronto Stock Exchange's S&P/TSX rose 122.87 points, or 0.82 percent, to 15,150.15 for its third straight day of gains. * Leading the index were Hudbay Minerals Inc, up 22.6 percent after announcing ...
Canada's main stock index rose on Thursday, boosted by gains in shares of metal miners fueled by rally in gold prices. * At 9:44 a.m. ET (13:44 GMT), the Toronto Stock Exchange's S&P/TSX composite index was up 52.27 points, or 0.35 percent, at 15,079.55. * The largest percentage gainers on the TSX were Hudbay Minerals, which jumped 11.2 percent after reporting quarterly results and announcing deal to buy Mason Resources Corp.
NEW YORK, NY / ACCESSWIRE / November 1, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...
* The Toronto Stock Exchange's S&P/TSX rose 132.78 points, or 0.89 percent, to 15,027.28, but still suffered its worst monthly performance since September 2011. * Leading the index were Aphria Inc, up ...
Canada's main stock index gained on Wednesday, driven by an increase in energy shares and 0.1 percent growth in the economy in August. * Statistics Canada said the country's gross domestic product growth ...
Leading up to the October 17th "legalization date" in Canada, investors saw a surge in cannabis stock interest. Canadian producers and retailers have been unable to keep up with the demand among consumers for cannabis products. With this in mind, we look at 3 marijuana stocks to watch as legalization continues to reach across North America.
Canada's main stock index reversed course to trade higher on Tuesday, led by gains in industrial stocks, after U.S. President Donald Trump said he thought there will "a great deal" with China on trade. * However, Trump warned he has billions of dollars worth of new tariffs ready to go if a deal isn't possible. * At 9:47 a.m. ET (13:47 GMT), the Toronto Stock Exchange's S&P/TSX composite index was up 75.46 points, or 0.51 percent, at 14,797.21.
LEAMINGTON, ON , Oct. 30, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH) and (US OTC: APHQF) announced today that its common shares have been approved for listing on the New York Stock Exchange ("NYSE") and will commence trading effective the open of markets on November 2, 2018 .
Cannabis will be legal in Canada starting this Wednesday, generating strong interest from investors eager to get in on a market that analysts and experts expect to be worth billions of dollars.
Aphria Inc. introduced Thursday Jonathan Simone as director of research and clinical studies. Shares of the Canada-based cannabis company shot up 8.9% in afternoon trade, after tumbling 26% over the previous seven sessions. Simone recently received his doctorate at Brock University in St. Catherines, Ontario, where he helped develop a multi-disciplinary cannabinoid research program. He has been recognized for his research on the role of the endocannabinoid system in neurodevelopment, and in the regulation of affective and cognitive behaviors. "Jonathan is a rising star in the medical cannabis research community and we are pleased to welcome him to the Aphria family," said Chief Executive Vic Neufeld. The stock has run up 53% over the past three months, while the ETFMG Alternative Harvest ETF has climbed 21% and the S&P 500 has given up 4.5%.
LEAMINGTON, ON , Oct. 25, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today officially introduced Dr. Jonathan Simone , PhD as the Company's Director of Research and Clinical Studies. Dr. Simone joined Aphria in July 2018 and serves as the primary liaison between the Company's science, technical and medical division teams and outside medical, academic and clinical centers.
CORAL GABLES, FL / ACCESSWIRE / October 25, 2018 / According to a new report by Grand View Research, Inc., the global legal marijuana market is expected to reach $146.4 billion by end of 2025. This week the market along with several cannabis stocks are looking to turn a corner and head back toward previous highs. Integrated Cannabis Company (ICNAF) (ICAN.CN) reported today that the marijuana company has agreed to license Cannabidiol-formulated gummies.
Investorideas.com, a global news source covering leading sectors including both cannabis and solar stocks, issues a snapshot looking at how solar energy has and will play a key role in the future of the cannabis sector. Companies mentioned: Aurora Cannabis Inc. (TSX: ACB.TO) (NYSE: ACB), Solar Integrated Roofing Corporation (OTC: SIRC), Canadian Solar Inc. (NASDAQ: CSIQ), Aphria Inc. (TSX: APH.TO), (OTC: APHQF), and Emerald Health Therapeutics, Inc.
Canada's main stock index edged lower on Monday as falling commodity prices pulled down energy and gold mining shares. * At 9:54 a.m. ET , the Toronto Stock Exchange's S&P/TSX composite index was down ...
Founded by two greenhouse operating veterans in the farming town of Leamington, Ontario, Aphria Inc. has grown into a company with a market of more than $6 billion thanks to a focus on cheaper production of cannabis.
Canada's main stock index rose on Friday after data showed annual inflation rate dipped as price pressures from gas and air travel eased. * At 9:48 a.m. ET , the Toronto Stock Exchange's S&P/TSX composite ...